Bulletin
Investor Alert

Johnson & Johnson

NYS: JNJ

GO
/marketstate/country/us

After Hours

JNJ
/zigman2/quotes/201724570/composite

$

159.65

Change

+0.27 +0.17%

Volume

Volume 1.67m

Dec 3, 2021, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201724570/composite

Previous close

$ 157.09

$ 159.38

Change

+2.29 +1.46%

Day low

Day high

$157.59

$159.67

Open
Open: 157.91

52 week low

52 week high

$148.51

$179.92

Open

Market cap

$419.58B

Average volume

7.21M

P/E ratio

23.82

Rev. per Employee

$613,918

EPS

6.69

Dividend

1.06

Div yield

2.66%

Ex dividend date

11/22/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/jnj

MarketWatch News on JNJ

  1. Johnson & Johnson stock outperforms competitors on strong trading day

    4:32 p.m. Dec. 3, 2021

    - MarketWatch Automation

  2. Johnson & Johnson stock falls Thursday, underperforms market

    4:32 p.m. Dec. 2, 2021

    - MarketWatch Automation

  3. Johnson & Johnson stock outperforms market on strong trading day

    4:32 p.m. Dec. 1, 2021

    - MarketWatch Automation

  4. Dow rallies 350 points on gains for Apple Inc., Johnson & Johnson shares

    12:33 p.m. Dec. 1, 2021

    - MarketWatch Automation

  5. Johnson & Johnson stock underperforms Tuesday when compared to competitors

    4:32 p.m. Nov. 30, 2021

    - MarketWatch Automation

  6. Johnson & Johnson stock rises Monday, still underperforms market

    4:32 p.m. Nov. 29, 2021

    - MarketWatch Automation

  7. The Key Issues in Picking an Active or Passive Fund

    2:48 p.m. Nov. 28, 2021

    - Lawrence C. Strauss

  8. Johnson & Johnson stock falls Wednesday, underperforms market

    4:32 p.m. Nov. 24, 2021

    - MarketWatch Automation

  9. S&P 500 Dividend Payouts Head Toward New Record in Rebound From Pandemic

    2:06 p.m. Nov. 24, 2021

    - Lawrence C. Strauss

  10. Johnson & Johnson COVID-19 vaccine receives full approval by Health Canada for adults

    7:49 a.m. Nov. 24, 2021

    - Tomi Kilgore

  11. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/jnj

Other News on JNJ

  1. 2 Robinhood Stocks to Buy and Hold for 10 Years

    10:30 a.m. Today

    - Motley Fool

  2. Will The Bull Market Continue In 2022? How To Invest Now?

    9:00 a.m. Today

    - Seeking Alpha

  3. 1 Green Flag for Moderna in 2022, and 1 Red Flag

    6:30 a.m. Today

    - Motley Fool

  4. What We Know About the New Variant

    6:18 p.m. Dec. 3, 2021

    - Gabriele Steinhauser

  5. How the NFL Ruled Antonio Brown’s Vaccine Card Was Forged

    10:13 a.m. Dec. 3, 2021

    - Louise Radnofsky

  6. FDA Aims for Speedy Review of Omicron Vaccines and Drugs

    7:00 a.m. Dec. 3, 2021

    - Felicia Schwartz

  7. More Omicron cases found in the U.S.

    4:00 p.m. Dec. 2, 2021

    - Seeking Alpha

  8. Scientists Studying Omicron See Rise in Covid-19 Reinfections

    3:54 p.m. Dec. 2, 2021

    - Gabriele Steinhauser

  9. Merck, Novartis in Line for Key FDA Approvals This Month

    2:30 p.m. Dec. 2, 2021

    - GuruFocus.com

  10. U.S. to Restart ‘Remain in Mexico’ Program for Asylum Seekers

    11:47 a.m. Dec. 2, 2021

    - Michelle Hackman

  11. Loading more headlines...
/news/pressrelease/company/us/jnj

Press Releases on JNJ

  1. Johnson & Johnson JNJ Trading Report

    7:24 p.m. Dec. 3, 2021

    - Stock Traders Daily

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.